Literature DB >> 2182162

Pulmonary hypertension due to chronic hypoxia.

A Peacock1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2182162      PMCID： PMC1662553          DOI： 10.1136/bmj.300.6727.763

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Pulmonary hypertension in chronic obstructive pulmonary disease: the right ventricular hypothesis.

Authors:  D A Morrison
Journal:  Chest       Date:  1987-09       Impact factor: 9.410

2.  Response of pulmonary circulation to oral pirbuterol in chronic airflow obstruction.

Authors:  A Peacock; C Busst; K Dawkins; D M Denison
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

3.  Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease.

Authors:  R M Oliver; A J Peacock; J S Fleming; D G Waller
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

4.  Nifedipine dilates the pulmonary vasculature without producing symptomatic systemic hypotension in upright resting and exercising patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.

Authors:  A Muramoto; J Caldwell; R K Albert; S Lakshminarayan; J Butler
Journal:  Am Rev Respir Dis       Date:  1985-11

5.  Effects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive pulmonary disease.

Authors:  D T Danahy; J M Tobis; W S Aronow; K Chetty; F Glauser
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

6.  Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study.

Authors:  T P Kennedy; J R Michael; C K Huang; C H Kallman; K Zahka; W Schlott; W Summer
Journal:  Am Rev Respir Dis       Date:  1984-04

7.  Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.

Authors:  E Weitzenblum; C Hirth; A Ducolone; R Mirhom; J Rasaholinjanahary; M Ehrhart
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

8.  Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension.

Authors:  C A Keller; J W Shepard; D S Chun; G F Dolan; P Vasquez; V D Minh
Journal:  Am Rev Respir Dis       Date:  1984-10

9.  Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.

Authors:  W MacNee; C G Wathen; W J Hannan; D C Flenley; A L Muir
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22
  9 in total
  4 in total

1.  Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.

Authors:  Constantinos Koumenis; Christine Naczki; Marianne Koritzinsky; Sally Rastani; Alan Diehl; Nahum Sonenberg; Antonis Koromilas; Bradly G Wouters
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

2.  Effect of single lung transplantation on pulmonary hypertension in patients with end stage fibrosing lung disease.

Authors:  J C Doig; P A Corris; C J Hilton; J H Dark; R S Bexton
Journal:  Br Heart J       Date:  1991-12

3.  Increased Post-Hypoxic Oxidative Stress and Activation of the PERK Branch of the UPR in Trap1-Deficient Drosophila melanogaster Is Abrogated by Metformin.

Authors:  Alma Kokott-Vuong; Jennifer Jung; Aaron T Fehr; Nele Kirschfink; Rozina Noristani; Aaron Voigt; Arno Reich; Jörg B Schulz; Michael Huber; Pardes Habib
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

4.  Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.

Authors:  Olga Rafikova; Mary L Meadows; Jason M Kinchen; Robert P Mohney; Emin Maltepe; Ankit A Desai; Jason X-J Yuan; Joe G N Garcia; Jeffrey R Fineman; Ruslan Rafikov; Stephen M Black
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.